I believe this is the year for RHT to multiply its income with so many TGA and FDA approved products , that at the market fiasco has now passed , management were very green lending shares to a company that gouged shareholders badly selling down and buying back at lows to make a quick buck , shares have been returned now ,bad luck if you needed to sell , , as RHT income rises the market will catch onto the cheap market cap . both med insurances and patients all want a quick safe scan instead of a dangerous and expensive biopsy operation , (the knife )
RHT Price at posting:
7.0¢ Sentiment: None Disclosure: Held
